Report overview
As per the International Federation of Pharmaceutical Manufacturers & Associations, out of the total expenditure on drug discovery, 25% is spent on preclinical testing. Implementation of single-domain antibodies for drug discovery saves money and shortens the very lengthy process, contributing to higher demand in the single-domain antibody platforms market.
This report aims to provide a comprehensive presentation of the global market for Single-Domain Antibody Platform, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Single-Domain Antibody Platform. This report contains market size and forecasts of Single-Domain Antibody Platform in global, including the following market information:
Global Single-Domain Antibody Platform Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
The global Single-Domain Antibody Platform market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Multi-Specific Single Domain Antibody Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Single-Domain Antibody Platform include Creative BioLabs A, Synbio Technologies, ProSci Incorporated, BioCat GmbH, Antibody Design Labs, GenScript, Oak BioSciences, Inc., Rockland Immunochemicals, Inc and Hybrigenics Services, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
We surveyed the Single-Domain Antibody Platform companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Single-Domain Antibody Platform Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Single-Domain Antibody Platform Market Segment Percentages, by Type, 2023 (%)
Multi-Specific Single Domain Antibody
Bispecific Single Domain Antibody
Multivalent Single Domain Antibody
Mono-Specific Single Domain Antibody
Global Single-Domain Antibody Platform Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Single-Domain Antibody Platform Market Segment Percentages, by Application, 2023 (%)
Diagnostic Laboratories
Clinical Laboratories
Academic and Research Institutes
Pharmaceutical and Biotechnology Companies
Global Single-Domain Antibody Platform Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Single-Domain Antibody Platform Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Single-Domain Antibody Platform revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Single-Domain Antibody Platform revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Creative BioLabs A
Synbio Technologies
ProSci Incorporated
BioCat GmbH
Antibody Design Labs
GenScript
Oak BioSciences, Inc.
Rockland Immunochemicals, Inc
Hybrigenics Services
NeoClone Biotechnology International LLC
Kaneka Eurogentec S.A
ProteoGenix
Outline of Major Chapters:
Chapter 1: Introduces the definition of Single-Domain Antibody Platform, market overview.
Chapter 2: Global Single-Domain Antibody Platform market size in revenue.
Chapter 3: Detailed analysis of Single-Domain Antibody Platform company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Single-Domain Antibody Platform in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
